ABSTRACT Regulating levels of centromeric histone H3 (CenH3) variant is crucial for genome stability. Interaction of Psh1, an E3 ligase, with the C terminus of Cse4 has been shown to contribute to its proteolysis. Here, we demonstrate a role for ubiquitination of the N terminus of Cse4 in regulating Cse4 proteolysis for faithful chromosome segregation and a role for Doa1 in ubiquitination of Cse4.
some segregation (Stoler et al. 1995; Meluh et al. 1998; Blower and Karpen 2001; Maddox et al. 2012) . Mis-localization and overexpression of CenH3 has been observed in cancers and associated with aneuploidy in Drosophila melanogaster (Tomonaga et al. 2003; Heun et al. 2006; Moreno-Moreno et al. 2006) . Studies from budding yeast and fruit flies have shown that proteolysis of CenH3 plays an important role in preventing its mis-localization MorenoMoreno et al. 2006 MorenoMoreno et al. , 2011 . Psh1, an E3 ligase, interacts with Cse4, the budding yeast CenH3, and mediates its ubiquitination for proteolysis (Hewawasam et al. 2010; Ranjitkar et al. 2010) . Despite ubiquitination of Cse4 by Psh1, Cse4 is only partially stabilized when overexpressed in psh1Δ strains (Hewawasam et al. 2010; Ranjitkar et al. 2010) , suggesting that additional factors regulate Cse4 protein stability.
In this study, we investigated the role of Cse4 domains in directing Cse4 proteolysis and used a genome-wide screen to identify pathways that regulate Cse4 stability. Since subcellular levels of Cse4 are stringently regulated, strains overexpressing CSE4 or cse4 mutants have been used to identify proteolytic pathways and factors such as Psh1 that mediate its degradation (Hewawasam et al. 2010; Ranjitkar et al. 2010) . We initiated our studies with a mutant cse416KR (16KR) and 16KR fusion mutants in which lysines (K) are mutated to arginines (R) (Figure 1 , A-C; Supporting Information, Table S1 and File S1). Overexpression of 16KR leads to defects in chromosome segregation, and this correlates with enrichment in chromatin and increased protein stability Au et al. 2008) . Our results show that the stability of CK (fusion of Cse4 N terminus amino acids 1-135 and 16KR C terminus) is low (t 1/2 = 26 6 6 min) and is comparable to that of Cse4 (t 1/2 = 34 6 3 min), indicating that the lack of ubiquitination of the C terminus due to K-to-R mutations does not increase protein stability. In contrast, the stability of KC (a fusion of 16KR N terminus and Cse4 C terminus) is high (t 1/2 . 120 min) and similar to 16KR (Figure 1 , B and C), showing that K-to-R mutations in the N terminus of Cse4 increase protein stability. Consistent with these results are previous observations showing that Cse4 lacking the N terminus (Δ129) is fivefold more stable than full-length Cse4 (Morey et al. 2004) . Increased Cse4 stability correlates with chromosome loss, as KC and 16KR strains exhibit fourfold higher chromosome loss than strains expressing CK or wild-type Cse4 ( Figure 1G ). Based on these results, we propose that the N terminus of Cse4 facilitates its proteolysis.
We next determined whether the N terminus of Cse4 promotes turnover of a heterologous protein, the histone fold domain of histone H3 (H3 HFD). We compared the stabilities of H3, H3 HFD, CH (Cse4 N terminus fused to H3 HFD), and KH (16KR N terminus fused to H3 HFD) ( Figure 1D ). Consistent with our hypothesis, the half-life of CH (t 1/2 = 31 6 5 min) is less than that of H3 HFD (t 1/2 = 119 6 20 min), H3 (t 1/2 = 49 min), or KH (t 1/2 . 120 min) (Figure 1, E and F) . The faster turnover of CH shows that the N terminus of Cse4 mediates proteolysis independently of the Cse4 C terminus.
Psh1 interacts with the CENP-A-targeting domain (CATD) (Black et al. 2007) and ubiquitinates Cse4 at its C terminus in vitro (Hewawasam et al. 2010; Ranjitkar et al. 2010) . However, the rapid turnover of both CK and CH, which lack C-terminal lysine residues for ubiquitination or the CATD, respectively, suggests that the N terminus of Cse4 must also contribute to its proteolysis. To investigate the role of Psh1 in N-terminal-mediated proteolysis, we examined the stability of Cse4 mutants in psh1Δ strains. As reported previously, Cse4 is more stable in the psh1Δ strains compared to wild type (t 1/2 = 50 vs. 34 min) (Figure 2 , A and B) (Hewawasam et al. 2010; Ranjitkar et al. 2010) . KC and KH were more stable than CK or CH (t 1/2 . 110-120 min vs. 46 min) in the psh1Δ strains, similar to their relative stabilities in the wildtype strain. Given the decreased turnover rate of CK and CH in psh1Δ strains compared to wild-type strains (t 1/2 ¼ 46 vs. 26 min and t 1/2 ¼ 46 vs. 31 min, respectively) ( Figure 1 , B and E, and Figure 2A ), we conclude that Psh1 only partially contributes to the N-terminal-mediated proteolysis of Cse4 independently of its C terminus. The increased stability of KC in wild-type strains compared to the stability of Cse4 or Figure 1 N-terminal tail of Cse4 regulates protein stability and faithful chromosome segregation. (A) The N terminus of Cse4 regulates its protein stability. We constructed plasmids expressing CSE4 with lysines (K) in the N terminus (1-135 amino acids) or the C terminus (136-229 amino acids) mutated to arginine (R) (shaded diagonals and asterisks denote the position of K) (see Table S1 ). KC denotes a fusion between the mutant N-terminal tail with all Ks changed to Rs and the wild-type C terminus of Cse4, whereas CK has the reverse configuration. Essential N-terminal domain (END) and CATD are as shown. (B) Western blot analysis of proteins prepared from a wild-type (YPH1018) strain with Cse4 (pSB816), 16KR (pSB817), KC (pMB1257), or CK (pMB1301) grown in raffinose/ galactose (2%) for 6 hr followed by growth in glucose (2%)-containing media with cycloheximide (CHX, 10 mg/ml) for the indicated time, as previously described (Au et al. 2008) . Blots were probed with anti-Myc (A-14, Santa Cruz, Inc.) and anti-Tub2 for a loading control. Tub2-normalized Cse4 protein levels after 120 min of CHX treatment is presented as percentage of remaining relative to the sample (t = 0; lane 1 = 100%). Protein half-lives were determined by least squares regression of log (percentage remaining) vs. time and reported as the mean 6 SD of three biological replicates. (C) The graph shows kinetics of turnover from B plotted on a semilog scale. (D) The N terminus of Cse4 regulates the stability of histone H3. We constructed plasmids expressing fusions of histone H3 (HHT1) with CSE4 or 16KR. Shaded diagonals correspond to that in A; dotted shading represents regions homologous to HHT1. (E) Western blot analysis of proteins prepared from a wild-type (YPH1018) strain with CH (pMB1263), KH (pMB1273), full-length H3 (pMB1581), or the H3 histone fold domain (H3 HFD) (pMB1582) as described in B. (F) The graph shows kinetics of turnover from E plotted on a semilog scale. (G) Mutations in the N terminus of Cse4 lead to increased chromosome loss. Strains expressing constructs from A were assayed for the loss of a reporter chromosome that results in half-red/half-white colonies due to reporter chromosome loss in the first division as described previously (Hieter et al. 1985) . Mean of three biological repeats with standard deviation is shown.
CK in psh1Δ strains suggests that there are additional pathways regulating Cse4 stability via its N terminus.
Finding a role for the Cse4 N terminus in regulating proteolysis prompted us to identify genes/pathways that mediate Cse4 turnover. A genome-wide screen using a synthetic genetic array (SGA) Costanzo et al. 2010) was employed to identify genes essential for growth when CSE4 is overexpressed (GALCSE4). The screen led to identification of genes, including DOA1 and PSH1, involved in ubiquitin-proteasome pathways (W. C. Au and M. A. Basrai, unpublished results) . The identification of PSH1 confirms GALCSE4 synthetic lethality in psh1Δ strains (Hewawasam et al. 2010; Ranjitkar et al. 2010) . To determine if the N-terminus-mediated proteolysis of Cse4 is ubiquitin-dependent, we pursued further studies of DOA1, which regulates cellular Ub levels (Johnson et al. 1995; Zhao et al. 2009 ). We validated the SGA results by confirming the lethality conferred by GALCSE4 in psh1Δ and doa1Δ strains ( Figure 2C ), and the phenotype correlates with greater stability of Cse4 in psh1Δ (t 1/2 = 50) and doa1Δ (t 1/2 . 120 min) strains (Figure 2, D and E) . In contrast to their rapid turnover in psh1Δ, CK and CH are more stable in doa1Δ strains (t 1/2 . 120 min) (Figure 2, D and E) . Furthermore, endogenously expressed Cse4 is also stabilized in doa1Δ strains ( Figure 2F and Table S2 ), showing that increased stability of Cse4 in these strains is not limited to overexpressed CSE4. Based on these results, we conclude that Psh1 is not the sole regulator of Cse4 proteolysis and that Doa1 facilitates Cse4 N-terminus-dependent proteolysis.
Doa1 regulates Ub levels in yeast cells (Johnson et al. 1995) . Since overexpression of UBI4 (encoding Ub) suppresses the phenotypes of doa1Δ (Finley et al. 1987; Lis and Romesberg 2006) , we reasoned that it might suppress the lethality of doa1Δ strains overexpressing CSE4. Overexpression of UBI4 Figure 2 Role of Doa1 in proteolysis of Cse4 in a Psh1-independent manner. (A) The Cse4 N-terminus-mediated proteolysis is not abolished in psh1Δ strains. Western blot analysis of proteins prepared from psh1Δ strains (BY4741, Open Biosystems) with Cse4 (pSB816), KC (pMB1257) and CK (pMB1301), and KH (pMB1273) and CH (pMB1263) grown in raffinose/galactose (2%) for 6 hr followed by treatment with cycloheximide (CHX, 10 mg/ml) for the indicated times in glucose (2%)-containing media as described (Au et al. 2008) . Blots were probed with anti-Myc and anti-Tub2 for a loading control. Tub2-normalized Cse4 protein level after 120 min of CHX treatment is presented as the percentage remaining relative to the sample (t = 0; lane 1 = 100%). The mean half-life (t 1/2 ) of two biological repeats is shown and is derived as in Figure 1B. (B) The graph shows kinetics of turnover from wild-type and psh1Δ strains plotted on a semilog scale. (C) Synthetic dosage lethality of GALCSE4 in doa1Δ and psh1Δ strains. Growth of serial dilutions of wild-type (WT) and doa1Δ and psh1Δ strains with vector or pMB1458 (GALCSE4) on glucose (2%)-or galactose (2%)-containing media at 30°for 4 days. (D) Cse4 and its chimeras are highly stable in doa1Δ strains. Protein stability assays are as described in A. The half-life (t 1/2 ) represents the mean of two biological repeats and is derived as in Figure 1B. (E) The graph shows kinetics of turnover plotted on a semilog scale. (F) Cse4 expressed from its own promoter is highly stable in doa1Δ strains. Western blot analysis of proteins prepared from wild-type (WT, YMB6398)-and doa1Δ (YMB8582)-expressing Myc-Cse4 integrated at the LEU2 locus as described in A except strains were grown in glucose (2%)-containing media. Half-life (t 1/2 ) represents the mean of three biological repeats with standard deviation. (G) Graph shows kinetics of turnover from F plotted on a semi log scale.
suppresses the lethality conferred by GALCSE4 ( Figure  3A ) and reduces the stability of Cse4 in doa1Δ strains ( Figure 3B ). Overexpression of UBI4 partially suppresses the GALCSE4-induced lethality of psh1Δ strains and reduces the stability of Cse4 ( Figure S1C ). These results provide further support for Psh1-independent proteolysis of Cse4 and suggest that Cse4 N-terminus-mediated proteolysis is ubiquitin-dependent.
We next asked if the N terminus of Cse4 is directly ubiquitinated, and we tested the requirement of DOA1 in this process. We performed affinity pull-down using agarose with tandem ubiquitin-binding entities (Ub + ) (Hjerpe et al. 2009 ) (see File S1) with strains expressing Myc-Cse4 or chimeric mutant proteins. Control samples with vector alone, 16KR, or Cse4 with agarose without Ub-binding activity (Ub 2 ) do not show laddering ( Figure 3C, lanes 12, 15,  19 ), but the detection of 16KR in Ub + suggests that nonmodified (NM) forms of Cse4 (arrow) interact with ubiquitinated proteins bound to Ub + . Consistent with our hypothesis for ubiquitination of the N terminus of Cse4, we observed a laddering pattern for Cse4, CK, and CH strains in the Ub + samples from wild-type strains, indicative of polyubiquitination of these proteins ( Figure 3C, lanes 13,  14, 18 ). The reduced laddering pattern of CK compared to Cse4 suggests that the lysines in the C terminus are ubiquitinated. Mutation of lysines in the N terminus (KC) show markedly diminished laddering, indicating that the N terminus is ubiquitinated and the interaction of Psh1 with the C terminus of Cse4 is not sufficient for ubiquitination ( Figure 3C , lane 16). Further evidence for ubiquitination of the N terminus Figure 3 DOA1 contributes to the ubiquitination of the N-terminal tail of Cse4. (A) Overexpression of UBI4 suppresses the synthetic lethality of doa1Δ strains overexpressing CSE4. Growth of serial dilutions of wild-type (WT), doa1D, and psh1D strains with 2m UBI4 (kindly provided by Charlie Boone), GALCSE4 (pMB1597), or both plasmids were assayed on glucose-or galactose-containing media at 30°for 4 days. (B) Overexpression of UBI4 decreases the stability of Cse4 in doa1Δ strains. Protein stability assays using strains from A grown in raffinose/ galactose (2%)-containing media for 2 hr, followed by treatment with cycloheximide (CHX, 10 mg/ml) for indicated times in glucose (2%)-containing media as described (Au et al. 2008 ) using anti-HA (12CA5, Roche Inc.). The halflife (t 1/2 ) represents the mean of two biological repeats is shown and is derived as in Figure 1B . The graph shows kinetics of turnover plotted on a semilog scale. (C) The N terminus of Cse4 is ubiquitinated in a DOA1-dependent pathway. Wild-type and doa1Δ strains expressing CSE4 or cse4 alleles were used for pull-down with control (Ub 2 ) or tandem ubiquitin-binding entities, Agarose-TUBE1 (Ub + ) (LifeSensors, Inc.; catalog nos. UM401 and UM400, respectively) followed by Western blot analysis with anti-Myc antibody (A-14, Santa Cruz Inc.) as described (File S1). Control agarose and non-HA-tagged (vector) strains were used as negative controls. Western blot analysis from doa1Δ strains was exposed for a longer time to rule out any residual laddering (lanes 20-23). (D) The N terminus of Cse4 mediates its ubiquitination. Wildtype (WT, YPH1015) and doa1D strains expressing HA-tagged Cse4 (pMB1458) or HA-tagged D129 (pMB1459) were assayed as described in C. CHX (10 mg/ml) treatment was carried out for 30 min (lanes 6 and 12). (E) doa1Δ strains show defects in ubiquitination of Cse4. Ratio of ubiquitinated HA-Cse4 (white box labeled "A" in panel D) to non-ubiquitinated HA-Cse4 (white box labeled "B" in panel D) in wildtype (WT) and doa1D strains from D were calculated. The graph represents the mean of three biological repeats with standard deviation.
of Cse4 is the observed laddering pattern of CH and the absence of laddering of H3HFD lacking the N terminus of Cse4 ( Figure 3C, lanes 18, 17) . Since CH lacks the Psh1-interacting domain, the observed ubiquitination is likely to be Psh1-independent. In contrast to in wild-type strains, ubiquitination of Cse4, CK, CH, and KC was barely detectable in doa1Δ strains ( Figure 3C, lanes 20-23) . Using HA-tagged Cse4, we observed a sevenfold reduction in high-molecular-weight forms of Cse4 in doa1Δ strains relative to wild type ( Figure 3D , lanes 8 and 10, and Figure 3E ). That the laddering was largely absent after cycloheximide treatment is consistent with the idea that the high-molecularweight isoforms represent polyubiquitinated Cse4 that is rapidly degraded ( Figure 3D, lane 12) . The lack of Cse4 ubiquitination in doa1Δ strains is consistent with increased stability of Cse4 proteins in these strains (Figure 2, D-G) .
Consistent with our hypothesis that the N terminus of Cse4 is ubiquitinated, a Cse4 mutant lacking the N terminus (Δ129) does not show laddering in wild-type or doa1Δ strains ( Figure 3D , lanes 9 and 11). Overexpression of UBI4 restores laddering of Cse4 in both doa1Δ and psh1Δ strains ( Figure S1A , lanes 14 and 14 s , and Figure S1B , lanes 9 and 10) but has no effect on the laddering for Δ129-expressing strains ( Figure S1A, lane 16) . The absence of laddering with Δ129 indicates that the N terminus of Cse4 is required for ubiquitination at the C terminus in vivo. Restoration of laddering similar to that observed for wild type upon overexpression of UBI4 in the psh1Δ mutant provides evidence for Psh1-independent mechanisms of Cse4 ubiquitination. Taken together, these results show that the N terminus of Cse4 is a target of ubiquitination and that DOA1 is required for ubiquitination and proteolysis of Cse4.
In summary, we have shown that the N terminus of Cse4 is a target of ubiquitination and that this modification plays a major role in regulating its proteolytic degradation to ensure faithful chromosome transmission. We propose that ubiquitination of the N and C termini of Cse4 by Psh1 and other Ub ligases in the presence of Doa1 regulates Cse4 proteolysis. Support for our conclusion is derived from observations showing that the N terminus of Cse4 mediates rapid turnover when fused with either mutant C terminus of Cse4 (CK) or a heterologous protein H3 (CH) in a Doa1-dependent manner. Consistent with these results, mutations in the N terminus of Cse4 (KC and KH) makes the protein highly stable. Furthermore, a mutant with a deletion of the N terminus (cse4Δ129) fails to be ubiquitinated. Our observations that overexpressed UBI4 can suppress the lethality conferred by GALCSE4 and increase the ubiquitination and proteolysis of Cse4 in psh1Δ strains provide evidence for additional pathways in addition to Psh1 that can ubiquitinate Cse4. Our results are in agreement with other studies on the role of post-translational modifications of histone N termini in chromatin structure and chromosome segregation (Choy et al. 2011 (Choy et al. , 2012 Samel et al. 2012) . Given the evolutionary conservation of CenH3, future studies to define mechanisms that regulate cellular levels of CenH3 may help us to better understand the link between CenH3 overexpression and its mislocalization observed in cancers. Figure S1 UBI4 over-expression increases the levels of ubiquitinated Cse4 in doa1∆, but not ∆129 in wild-type. (A) Wild-type (WT, YPH1015) and doa1∆ strains expressing HA-tagged Cse4 (pMB1458) or ∆129 (pMB1459) with (+) or without (-) 2µ UBI4 were used for pull-down with tandem ubiquitin-binding entities, Agarose-TUBE1, (Pull down: Ub) (LifeSensors, Inc. Cat Catalog #: UM400) followed by western blot analysis with anti-HA antibody (12CA5, Roche, Inc.) or anti-Tub2 (loading control) as described (File S1). Non-modified (NM) and Cse4-ubiquitin conjugates (Ub) are shown. A shorter exposure of lane 14 (14 S ) of the pull-down is shown for better resolution of the ubiquitinated Cse4 pattern. Over-expression of UBI4 fails to increase ubiquitination of ∆129. (B) Over-expression of UBI4 restores Cse4 ubiquitination in psh1∆. Experiment was done as in (A) using WT and psh1∆ strains expressing HA-tagged Cse4 (pMB1597) with (+) or without (-) UBI4 over-expression. Lanes 4, 5, 9, and 10 are biological replicates. Non-modified (NM) and Cse4-ubiquitin conjugates (Ub) are shown. (C) Over-expression of UBI4 decreases the half-life of Cse4 in psh1∆. psh1∆ strains containing pMB1597 with or without 2µ UBI4 grown in raffinose (2%) were treated with galactose (2%) for 2 h followed by growth in glucose (2%)-containing media with cycloheximide (CHX, 10 µg/ml) for the indicated time, as previously described (AU et al. 2008) . Blots were probed with anti-HA (12CA5, Roche, Inc) and anti-Tub2 for a loading control. The graph shows kinetics of turn-over of normalized protein plotted on a semi-log scale. and GAL-13Myc-KH (pMB1273), respectively. Full length or the C-terminus (containing the HFD) of H3 were cloned in frame with 13Myc into pSB816 with CSE4 removed to create GAL-13Myc-HHT1 (H3) (pMB1581) and GAL-13Myc-H3HFD (pMB1582),
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respectively. Synthetic Genetic Array (SGA) was performed as previously described . Query strain (Y7092)
over-expressing HA-tagged Cse4 (R425-R10) as the only CSE4 copy in the genome was constructed using method described previously (LONGTINE et al. 1998 ).
Ubiquitin Affinity Pull-Down Assays
Strains were grown in raffinose-containing (2%) medium to the logarithmic phase after which galactose (2%) was added for 2 hours. Five minutes before harvesting, yeast cultures were with treated with sodium azide (0.1%). For pull-down, yeast cells were lysed by vortexing for 1 hour or bead-beating (3 times, 2 min) at 4 0 in cell lysis buffer (20mM Na 2 HPO 4 , 20mM NaH 2 PO 4 , 50mM NaF, 5mM tetra-sodium pyrophosphate, 10mM beta-glycerolphosphate, 2mM EDTA, 1 mM DTT, 1% NP-40, 5 mM NEthylmaleimide, 1mM PMSF and yeast protease inhibitor cocktail (Sigma, cat# P8215) with an equal volume of glass beads (425-600 µM). Cell lysate used for pull-downs was normalized by protein concentration (a fraction was saved as input) and incubated with 25 µl of tandem ubiquitin-binding entities Agarose-TUBE1 that displays high affinity to polyubiquitin chain (K48 linkage) and is also applicable to pull down mono ubiquitinated protein, or control agarose (LifeSensors, Inc. Catalog #: UM401, UM400, respectively) at 4 0 overnight and washed in Tris-buffered saline with Tween-20 (0.1%) (TBS-T) at room temperature. The bound proteins were then eluted in 2X Laemmli buffer at 100 0 for 10 min. The resulting samples were resolved on 4-12% gradient gel, and western blot analysis was carried out using anti-HA (12CA5 Roche, Inc.) or anti-Myc (A-14, Santa Cruz, Inc) antibody.
